Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Unknown Primary × veliparib × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Glioblastoma 4 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2 Glioma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1

Interventions

Paclitaxel 6 Carboplatin 6 Gemcitabine 3 Irinotecan 2 Erlotinib Hydrochloride 2 Capecitabine 2 Bevacizumab 2 sintilimab 1 pertuzumab 1 pemigatinib 1 pembrolizumab 1 olaparib 1 ivosidenib 1 ipatasertib 1 etoposide phosphate 1 erythromycin propionate-N-acetylcysteinate 1 entrectinib 1 cobimetinib 1 belinostat 1 atezolizumab 1 antineoplaston AS 2-1 1 antineoplaston A10 1 alectinib 1 Vemurafenib 1 Oxaliplatin 1 HhAntag691 1 Everolimus 1 Etoposide 1 Cisplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡